Organization WH. Noncommunicable diseases country profiles; 2018. p. 2018.
Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40:195–211.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 Western prospective studies. Circulation. 2007;115:450–8.
Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41:99–109.
Klempfner R, Erez A, Sagit B-Z, Goldenberg I, Fisman E, Kopel E, et al. Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease. Circulation. 2016;9:100–8.
Chen H, Chen WW, Chen WX, Dong YG, Gao W, Gao Y, et al. Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2016;2018:15.
Fan W, Philip S, Granowitz C, Toth PP, Wong ND. Prevalence of US adults with triglycerides ≥ 150 mg/dl: NHANES 2007–2014. Cardiol Ther. 2020;9:207–3.
Karpov Y, Khomitskaya Y. PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia. Cardiovasc Diabetol. 2015;14:1–14.
Endocrine Society. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia. Am Fam Physician. 2013;88:142.
Aekplakorn W. Thai National Health Examination V (NHES V); 2014.
Aekplakorn W. Thai National Health Examination VI (NHES VI); 2019.
Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2022;12:7726.
Thai hypertension society. 2019 Thai guidelines on the treatment of hypertension. 1st ed. Chiangmai: Trickthink; 2019;1:3–6.
Al-Zahrani J, Shubair MM, Al-Ghamdi S, Alrasheed AA, Alduraywish AA, Alreshidi FS, et al. The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey. BMC Cardiovasc Disord. 2021;21:1–8.
American Diabetes Association. Executive summary: standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl):1.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.
Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid AK, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd; 2000.
Pal S. Hypercholesterolemia trends. US: Pharmacist; 2021. p. 46.
Cui M, Chiang C, Cui R, Honjo K, Yatsuya H, Watson BM, et al. Prevalence and correlates of dyslipidemia among men and women in Palau: findings of the Palau STEPS survey 2011–2013. J Epidemiol. 2019;29:JE20170127.
Upala P, Apidechkul T, Wongfu C, Khunthason S, Kullawong N, Keawdounglek V, et al. Factors associated with hypertriglyceridemia among the hill tribe people aged 30 years and over, Thailand: a cross-sectional study. BMC Public Health. 2021;21:1–9.
Sakboonyarat B, Pima W, Chokbumrungsuk C, Pimpak T, Khunsri S, Ukritchon S, et al. National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018. Sci Rep. 2021;11:14260.
Reiner Ž. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14:401–11.
Antonios N, Angiolillo DJ, Silliman S. Hypertriglyceridemia and ischemic stroke. Eur Neurol. 2008;60:269–78.
Lisak M, Demarin V, Trkanjec Z, Bašić-Kes V. Hypertriglyceridemia as a possible independent risk factor for stroke. Acta Clin Croat. 2015;52:458–62.
Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopkins PN, Glasser SP, et al. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis. 2009;203:633–39
Kim SK, Kim HC, Shim JS, Kim DJ. Effects of cigarette smoking on blood lipids in korean men: cardiovascular and metabolic diseases etiology research center cohort. Korean J Intern Med. 2020;35:369.
Gossett LK, Johnson HM, Piper ME, Fiore MC, Baker TB, Stein JH. Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol. 2009;3:372–8.
Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y, et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J. 2006;70:593–9.
Ozguner F, Koyu A, Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health. 2005;21:21–26.
Hulea SA, Olinescu R, Nita S, Crocnan D, Kummerow FA. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J Environ Pathol Toxicol Oncol. 1995;14:173–80.
Al-Aubaidy HA, Jelinek HF. Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes. Redox Rep. 2014;19:87–91.
Moradinazar M, Pasdar Y, Najafi F, Shahsavari S, Shakiba E, Hamzeh B, et al. Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran. BMC Public Health. 2020;20:1–10.
Ruidavets JB, Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the prospective epidemiological study of myocardial infarction (PRIME). BMJ (Online). 2010;341:1–11.
Park H, Kim K. Relationship between alcohol consumption and serum lipid levels in elderly Korean men. Arch Gerontol Geriatr. 2012;55:226–30.
Foerster M, Marques-Vidal P, Gmel G, Daeppen JB, Cornuz J, Hayoz D, et al. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol. 2009;103:361–8.
Tolstrup JS, Grønbæk M, Nordestgaard BG. Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes. Circulation. 2009;2:507–14.
Ruidavets JB, Ducimetière P, Arveiler D, Amouyel P, Bingham A, Wagner A, et al. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health. 2002;56:24–28.
Whitfield JB, Heath AC, Madden PAF, Pergadia ML, Montgomery GW, Martin NG. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcohol Clin Exp Res. 2013;37:575–86.
Chantkran W, Chaisakul J, Rangsin R, Mungthin M, Sakboonyarat B. Prevalence of and factors associated with stroke in hypertensive patients in Thailand from 2014 to 2018: a nationwide cross-sectional study. Sci Rep. 2021;11:17614.
Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010;8:917–32.
Oshunbade AA, Kassahun-Yimer W, Valle KA, Hamid A, Kipchumba RK, Kamimura D, et al. Cigarette smoking, incident coronary heart disease, and coronary artery calcification in black adults: the Jackson heart study. J Am Heart Assoc. 2021;10:e017320.
Gibbs BB, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, et al. Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: a scientific statement from the American Heart Association. Hypertension. 2021;78(2):26–e37.
Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483–92.
Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med. 2009;48:9–19.
Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion - protection against triggering by regular exertion. N Engl J Med. 1993;329:1677–83.
Nutong R, Mungthin M, Hatthachote P, Ukritchon S, Imjaijit W, Tengtrakulcharoen P, et al. Personal risk factors associated with heat-related illness among new conscripts undergoing basic training in Thailand. Plos One. 2018;13:e0203428.
Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320:2020–8.
Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050–60.
Wang H, Chen Y, Guo X, Chang Y, Sun Y. Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China. Postgrad Med. 2017;129:834–41.
Capuano V, Marchese F, Capuano R, Iannone AG, Lamaida N, Capuano E, et al. Burden of Cardiometabolic risk factors on cerebrovascular events in a southern Italian population. World J Cardiovasc Dis. 2021;11:145.
Carrillo-Larco RM, Stern D, Hambleton IR, Hennis A, di Cesare M, Lotufo P, et al. Impact of common cardio-metabolic risk factors on fatal and non-fatal cardiovascular disease in Latin America and the Caribbean: an individual-level pooled analysis of 31 cohort studies. Lancet Reg Health Am. 2021;4:100068.
Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: a nation-wide, cross-sectional survey. BMC Cardiovasc Disord. 2018;18:151.
van de Woestijne AP, Monajemi H, Kalkhoven E, FLJ V. Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev. 2011:12:829–40.
Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218–40.
Institute of Medicine. Weight Management: State of the Science and Opportunities for Military Programs. In: Weight Management: State of the Science and Opportunities for Military Programs; 2004.
Ko I-G, Choi P-B. Regular exercise modulates obesity factors and body composition in sturdy men. J Exerc Rehabil. 2013;9:256.
Charoensri S, Turnsaket S, Pongchaiyakul C. Hypertriglyceridemia as an independent predictor for ten-year incidence of diabetes in thais. Vasc Health Risk Manag. 2021;17:519.
Parhofer KG. Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clin Lipidol. 2011;6:401–11.
Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002;106:1211–18.
Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–97.
Lin CC, Li TC, Lai SW, Li CI, Wang KC, Tan CK, et al. Epidemiology of hypertriglyceridemia in the elderly Taiwanese population. McGill J Med. 2001;6:1.
Mogane C, Mokotedi LP, Millen AME, Michel FS. Increased systolic blood pressure associated with hypertriglyceridemia in female Sprague-Dawley rats. Can J Physiol Pharmacol. 2019;97:971–9.
Howard G, Banach M, Cushman M, Goff DC, Howard VJ, Lackland DT, et al. Is blood pressure control for stroke prevention the correct goal?: the lost opportunity of preventing hypertension. Stroke. 2015;46:1595–1600.
Ruiz-García A, Arranz-Martínez E, López-Uriarte B, Rivera-Teijido M, Palacios-Martínez D, Dávila-Blázquez GM, et al. Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study. Clinica e Investigacion en Arteriosclerosis. 2020;32:242–55.
Ayata C, Shin HK, Dileköz E, Atochin DN, Kashiwagi S, Eikermann-Haerter K, et al. Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect. J Cereb Blood Flow Metab. 2013;33:954–62.
Leppälä JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30:2535–40.
Agabiti Rosei E, Salvetti M. Management of hypercholesterolemia, appropriateness of therapeutic approaches and new drugs in patients with high cardiovascular risk. High Blood Press Cardiovasc Prev. 2016;23:217–30.
S. Mannu GJS, Zaman M, Gupta AU, Rehman HK, Myint P. Evidence of lifestyle modification in the management of hypercholesterolemia. Curr Cardiol Rev. 2013;9:2–14.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
Prasad D, Kabir Z, Suganthy J, Dash A, Das B. Appropriate anthropometric indices to identify cardiometabolic risk in South Asians. WHO South East Asia J Public Health. 2013;2:142–48.